세계의 의약품용 배리어 포장 재료 시장 보고서(2025년)
Barrier Packaging Materials For Pharmaceuticals Global Market Report 2025
상품코드 : 1877541
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,684,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,662,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,639,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

의약품용 배리어 포장 재료 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2024년 301억 5,000만 달러에서 2025년에는 330억 7,000만 달러에 달하고, CAGR 9.7%를 나타낼 것으로 전망되고 있습니다. 과거의 성장은 안전한 의약품 보관에 대한 수요 증가, 의약품 생산량의 확대, 제품 오염에 대한 의식 증가, 콜드체인 물류의 확충, 의약품 사고에 대한 경계감의 증대에 의해 견인되어 왔습니다.

의약품용 배리어 포장 재료 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 472억 9,000만 달러에 달하고, CAGR은 9.4%를 나타낼 전망입니다. 예측 기간 동안의 성장은 바이오 의약품에 대한 투자 증가, 의약품 분야 전자상거래의 상승, 개인화된 의료의 확대, 지속가능성에 대한 주목 증가, 높은 배리어 포장 솔루션에 대한 수요 증가로 이어질 전망입니다. 예측 기간의 주요 동향은 다층 필름의 기술적 진보, 생분해성 배리어 재료의 진전, 스마트 포장 및 액티브 포장의 혁신, 새로운 장벽 유형의 개발, 배리어 포장에 대한 환경 친화적인 재료의 통합을 포함합니다.

향후 수년간 생물학적 제제의 성장이 의약품 시장을 위한 배리어 포장 재료의 확대를 이끌 것으로 예측됩니다. 생물학적 제제는 기존 화학물질에서 효과적으로 관리할 수 없는 질병을 치료하는 데 사용되는 살아있는 세포와 생물학적 치료 제품입니다. 생물학적 제제 수요 증가는 표적을 좁히는 효과적인 치료법이 필요한 만성 질환과 복잡한 질환의 유병률 상승에 기인합니다. 의약품 배리어 포장 재료는 생물학적 제제를 습기, 산소, 빛, 미생물 오염으로부터 보호함으로써 약물의 안전성과 안정성을 향상시킵니다. 이러한 재료는 열화 방지, 보존 기간 연장, 제품 효능 유지에 기여하며 환자의 안전을 보장합니다. 예를 들어 영국에 본사를 둔 비정부 조직인 유럽 의약품 검토(EPR)에 따르면, 2022년 5월 시점에서 생물학적 제제는 향후 5년 이내에 혁신적인 저분자 의약품의 매출을 크게 웃돌았으며, 2027년까지 약 1,200억 달러의 매출 증가가 전망됩니다. 따라서 생물학적 제제의 확대는 의약품 배리어 포장 재료 시장의 성장을 가속하고 있습니다.

의약품 배리어 포장 재료 시장에서 사업을 전개하는 주요 기업은 의약품 안정성 향상, 보존 기간 연장, 환자 안전 확보를 목적으로 한 혁신적인 의약품 포장 등 첨단 솔루션 개발에 주력하고 있습니다. 혁신적인 의약품 포장 솔루션에는 장벽재, 변조 방지 부품, 디지털 추적 기술 등을 특징으로 하는 약제 보호 향상, 제품 무결성 유지, 보관 및 운송 최적화를 도모하는 현대적인 방법이 채용되고 있습니다. 예를 들어, 2025년 2월에는 이스라엘에 본사를 둔 제조업체 LOG Pharma Primary Packaging사가 의약품을 지키는 지속가능하고 고성능의 포장 솔루션을 제공하기 위해 Pharmapack Europe에서 새로운 배리어 에코라인을 발표했습니다. 이 솔루션은 탁월한 방습 및 방산 차단성을 유지하면서 약품의 안정성을 보장하면서 병 중량을 최대 30%까지 줄입니다. 다우사의 선진적인 의약품 그레이드 수지 「HEALTH」를 채용해, 성능을 손상시키지 않고 환경 부하를 최소한으로 억제한, 지속 가능하고 코스트 효율이 높은 포장을 실현합니다. 이 혁신은 제약 회사가 지속가능성 목표를 달성하고 포장 비용을 줄이면서 약효를 유지하는 데 기여합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Barrier packaging materials for pharmaceuticals are specialized packaging solutions developed to protect pharmaceutical products from environmental factors such as moisture, oxygen, light, and microbial contamination. These materials help maintain the stability, efficacy, and shelf life of drugs by preventing degradation and ensuring consistent product quality during storage and transportation.

The main material types of barrier packaging materials for pharmaceuticals include aluminum foil barrier materials, polymer film barrier materials, multi-layer barrier systems, and advanced barrier technologies. Aluminum foil barrier materials consist of thin aluminum sheets used in pharmaceutical packaging to shield drugs from moisture, light, and oxygen, thereby preserving stability and extending shelf life. These materials are utilized in various packaging formats such as blister packaging, flexible packaging, rigid packaging, and specialized packaging designs. They are applied in solid dosage forms, liquid and semi-solid formulations, and biologics and biosimilars, with end users including branded drug manufacturers, generic drug companies, and contract development and manufacturing organizations (CDMOs).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The barrier packaging materials for pharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides barrier packaging materials for pharmaceuticals market statistics, including barrier packaging materials for the pharmaceuticals industry's global market size, regional shares, competitors with barrier packaging materials for pharmaceuticals market share, detailed barrier packaging materials for pharmaceuticals market segments, market trends and opportunities, and any further data you may need to thrive in the barrier packaging materials for the pharmaceuticals industry. This barrier packaging materials for the pharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The barrier packaging materials for pharmaceuticals market size has grown strongly in recent years. It will grow from $30.15 billion in 2024 to $33.07 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth during the historic period was driven by the increasing demand for safe drug storage, rising pharmaceutical production, growing awareness of product contamination, expansion of cold chain logistics, and heightened awareness of medication mishaps.

The barrier packaging materials for pharmaceuticals market size is expected to see strong growth in the next few years. It will grow to $47.29 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth during the forecast period will result from increasing investment in biopharmaceuticals, the rise of e-commerce in the pharmaceutical sector, the expansion of personalized medicine, growing focus on sustainability, and increasing demand for high-barrier packaging solutions. Major trends in the forecast period include technological advancements in multilayer films, progress in biodegradable barrier materials, innovation in smart and active packaging, development of new barrier types, and integration of eco-friendly materials in barrier packaging.

The growth of biologic drugs is expected to drive the expansion of the barrier packaging materials for the pharmaceuticals market in the coming years. Biologic drugs are therapeutic products derived from living cells or organisms that are used to treat diseases not effectively managed by traditional chemical drugs. The rising demand for biologic drugs is attributed to the increasing prevalence of chronic and complex diseases that require targeted and effective treatment options. Barrier packaging materials for pharmaceuticals enhance drug safety and stability by protecting biologic drugs from moisture, oxygen, light, and microbial contamination. These materials help prevent degradation, extend shelf life, and maintain product efficacy, ensuring patient safety. For example, in May 2022, according to the European Pharmaceutical Review (EPR), a UK-based non-governmental organization, biologics are projected to significantly surpass sales of innovative small molecules within the next five years, with an estimated $120 billion increase in sales by 2027. Therefore, the expansion of biologic drugs is fueling the growth of the barrier packaging materials for the pharmaceuticals market.

Major companies operating in the barrier packaging materials for pharmaceuticals market are focusing on developing advanced solutions such as innovative pharmaceutical packaging to enhance drug stability, extend shelf life, and ensure patient safety. Innovative pharmaceutical packaging solutions involve modern approaches that improve drug protection, maintain product integrity, and optimize storage and transportation, often featuring barrier materials, tamper-evident components, or digital tracking technologies. For example, in February 2025, LOG Pharma Primary Packaging, an Israel-based manufacturing company, introduced a new barrier eco line at Pharmapack Europe to provide sustainable, high-performance packaging solutions that safeguard pharmaceuticals. This solution reduces bottle weight by up to 30% while maintaining excellent moisture and oxygen barrier protection to ensure drug stability. It incorporates advanced pharma-grade HEALTH+ resins from Dow, offering sustainable, cost-effective packaging that minimizes environmental impact without compromising performance. This innovation helps pharmaceutical companies achieve sustainability objectives and lower packaging costs while maintaining drug efficacy.

In February 2025, Perlen Packaging AG, a Switzerland-based manufacturing company, acquired Log Pharma Industries for an undisclosed amount. Through this acquisition, Perlen Packaging AG aims to strengthen its global presence and expand its capabilities in pharmaceutical packaging by integrating Log Pharma's complementary products and increasing its manufacturing reach in key growth markets. Log Pharma Industries is an Israel-based pharmaceutical company that provides barrier packaging materials for pharmaceuticals.

Major players in the barrier packaging materials for pharmaceuticals market are BASF SE, Honeywell International Inc., 3M Company, Amcor plc, DuPont de Nemours Inc., Toppan Printing Co. Ltd., Dai Nippon Printing Co. Ltd., Mondi Group, Sealed Air Corporation, AptarGroup Inc., West Pharmaceutical Services Inc., Gerresheimer AG, ProAmpac Holdings LLC, UFlex Limited, SCHOTT AG, Toray Plastics (America) Inc., Cosmo Films Limited, Sonoco Products Company, Glenroy Inc., Cadillac Products Packaging Company, Origin Pharma Packaging Ltd., Neelam Global Pvt. Ltd., and Vishakha Polyfab Private Limited.

North America was the largest region in the barrier packaging materials for pharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in barrier packaging materials for the pharmaceuticals report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the barrier packaging materials for the pharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The barrier packaging materials for the pharmaceuticals market consists of sales of blister packs, high-barrier plastic bottles, pouches, vials, ampoules, and sachets. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Barrier Packaging Materials For Pharmaceuticals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on barrier packaging materials for pharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for barrier packaging materials for pharmaceuticals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The barrier packaging materials for pharmaceuticals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Barrier Packaging Materials For Pharmaceuticals Market Characteristics

3. Barrier Packaging Materials For Pharmaceuticals Market Trends And Strategies

4. Barrier Packaging Materials For Pharmaceuticals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Barrier Packaging Materials For Pharmaceuticals Growth Analysis And Strategic Analysis Framework

6. Barrier Packaging Materials For Pharmaceuticals Market Segmentation

7. Barrier Packaging Materials For Pharmaceuticals Market Regional And Country Analysis

8. Asia-Pacific Barrier Packaging Materials For Pharmaceuticals Market

9. China Barrier Packaging Materials For Pharmaceuticals Market

10. India Barrier Packaging Materials For Pharmaceuticals Market

11. Japan Barrier Packaging Materials For Pharmaceuticals Market

12. Australia Barrier Packaging Materials For Pharmaceuticals Market

13. Indonesia Barrier Packaging Materials For Pharmaceuticals Market

14. South Korea Barrier Packaging Materials For Pharmaceuticals Market

15. Western Europe Barrier Packaging Materials For Pharmaceuticals Market

16. UK Barrier Packaging Materials For Pharmaceuticals Market

17. Germany Barrier Packaging Materials For Pharmaceuticals Market

18. France Barrier Packaging Materials For Pharmaceuticals Market

19. Italy Barrier Packaging Materials For Pharmaceuticals Market

20. Spain Barrier Packaging Materials For Pharmaceuticals Market

21. Eastern Europe Barrier Packaging Materials For Pharmaceuticals Market

22. Russia Barrier Packaging Materials For Pharmaceuticals Market

23. North America Barrier Packaging Materials For Pharmaceuticals Market

24. USA Barrier Packaging Materials For Pharmaceuticals Market

25. Canada Barrier Packaging Materials For Pharmaceuticals Market

26. South America Barrier Packaging Materials For Pharmaceuticals Market

27. Brazil Barrier Packaging Materials For Pharmaceuticals Market

28. Middle East Barrier Packaging Materials For Pharmaceuticals Market

29. Africa Barrier Packaging Materials For Pharmaceuticals Market

30. Barrier Packaging Materials For Pharmaceuticals Market Competitive Landscape And Company Profiles

31. Barrier Packaging Materials For Pharmaceuticals Market Other Major And Innovative Companies

32. Global Barrier Packaging Materials For Pharmaceuticals Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Barrier Packaging Materials For Pharmaceuticals Market

34. Recent Developments In The Barrier Packaging Materials For Pharmaceuticals Market

35. Barrier Packaging Materials For Pharmaceuticals Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기